Emergent BioSolutions (EBS) is up 5.3%, or 49c to $9.74.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EBS:
- Emergent BioSolutions initiated with a Buy at H.C. Wainwright
- Mpox spreading in Congo’s capital, NY Times reports
- Emergent BioSolutions receives $50M contract option from BARDA
- WHO determines mpox upsurge still constitutes public health emergency
- Emergent BioSolutions files to sell 3.61M shares of common stock for holders